CORC

在结果中检索

CORC

浏览/检索结果: 共66条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Mechanistic insights into interfacial nano-synergistic effects in trimetallic Rh-on-NiCo on-CNTs for room temperature solvent-free hydrogenations 期刊论文
APPLIED CATALYSIS B-ENVIRONMENTAL, 2021, 卷号: 297, 页码: 14
作者:  Zhu, Lihua;  Zhu, Huaze;  Shakouri, Mohsen;  Zeng, Linghai;  Yang, Zhiqing
收藏  |  浏览/下载：31/0  |  提交时间：2021/11/22
Mechanistic insights into interfacial nano-synergistic effects in trimetallic Rh-on-NiCo on-CNTs for room temperature solvent-free hydrogenations 期刊论文
APPLIED CATALYSIS B-ENVIRONMENTAL, 2021, 卷号: 297, 页码: 14
作者:  Zhu, Lihua;  Zhu, Huaze;  Shakouri, Mohsen;  Zeng, Linghai;  Yang, Zhiqing
收藏  |  浏览/下载：22/0  |  提交时间：2021/11/22
Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma A SEER population-based study 期刊论文
MEDICINE, 2021, 卷号: 100
作者:  Lu, Yan;  Hua, Jianfeng;  Yan, Fengqin;  Jiang, Chuner;  Piao, Yongfeng
收藏  |  浏览/下载：42/0  |  提交时间：2021/08/30
The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma 期刊论文
ONCOLOGY RESEARCH, 2021, 卷号: 28
作者:  Piao Yongfeng;  Jiang Chuner;  Wang Lei;  Yan Fengqin;  Ye Zhimin
收藏  |  浏览/下载：58/0  |  提交时间：2021/05/06
Therapeutic patterns and outcomes in older patients (aged >= 65 years) with stage II-IVB Nasopharyngeal Carcinoma: an investigational study from SEER database 期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11
作者:  Piao, Yongfeng;  Jiang, Chuner;  Yan, Fengqin;  Ye, Zhimin;  Fu, Zhenfu
收藏  |  浏览/下载：25/0  |  提交时间：2020/10/26
Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy 期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11
作者:  
收藏  |  浏览/下载：33/0  |  提交时间：2020/11/26
Fabrication and mechanical properties of porous Si3N4 ceramics prepared via SHS 期刊论文
CERAMICS INTERNATIONAL, 2019, 卷号: 45, 期号: 12, 页码: 14867
作者:  
收藏  |  浏览/下载：58/0  |  提交时间：2019/12/26
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace